- Home
- IRON vs CAPL Comparison
IRON vs CAPL Comparison
Compare IRON & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- CAPL
- Stock Information
- Founded
- IRON 2017
- CAPL 1992
- Country
- IRON United States
- CAPL United States
- Employees
- IRON N/A
- CAPL N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- CAPL Oil Refining/Marketing
- Sector
- IRON Health Care
- CAPL Energy
- Exchange
- IRON Nasdaq
- CAPL Nasdaq
- Market Cap
- IRON 839.3M
- CAPL 715.7M
- IPO Year
- IRON N/A
- CAPL 2012
- Fundamental
- Price
- IRON $47.70
- CAPL $21.18
- Analyst Decision
- IRON Buy
- CAPL
- Analyst Count
- IRON 8
- CAPL 0
- Target Price
- IRON $64.13
- CAPL N/A
- AVG Volume (30 Days)
- IRON 147.4K
- CAPL 36.1K
- Earning Date
- IRON 11-07-2024
- CAPL 11-05-2024
- Dividend Yield
- IRON N/A
- CAPL 10.13%
- EPS Growth
- IRON N/A
- CAPL N/A
- EPS
- IRON N/A
- CAPL 0.56
- Revenue
- IRON N/A
- CAPL $3,996,818,000.00
- Revenue This Year
- IRON N/A
- CAPL $14.36
- Revenue Next Year
- IRON N/A
- CAPL N/A
- P/E Ratio
- IRON N/A
- CAPL $36.96
- Revenue Growth
- IRON N/A
- CAPL N/A
- 52 Week Low
- IRON $25.60
- CAPL $18.43
- 52 Week High
- IRON $77.60
- CAPL $24.19
- Technical
- Relative Strength Index (RSI)
- IRON 52.59
- CAPL 64.73
- Support Level
- IRON $48.00
- CAPL $19.42
- Resistance Level
- IRON $52.60
- CAPL $20.84
- Average True Range (ATR)
- IRON 1.91
- CAPL 0.40
- MACD
- IRON -0.32
- CAPL 0.14
- Stochastic Oscillator
- IRON 19.57
- CAPL 100.00
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver, includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K and through company operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites and the retail sale of motor fuel at retail sites operated by commission agents.